Entero Healthcare Solutions Limited — Updates, 27-01-2026: General Updates
27-01-2026 | 07:50 pm
27-01-2026 | 07:50 pm
Entero Healthcare's subsidiary, Atreja Healthcare, had its drug license temporarily suspended for three days due to violations. The company expects no material impact on overall operations, with a potential revenue loss of Rs 1.88 million.
No comments yet. Be the first to comment!
